Eventide Asset Management’s Evommune EVMN Stock Holding History
Bought
Maintained
Sold
Other funds holding EVMN
BBA
KCM
Eventide Asset Management's EVMN Position: Q3 2026 in Review
Eventide Asset Management sold out of Evommune (EVMN) in Q3 2026, closing a stake of 1,209,129 shares — an estimated $16.1M sold.
Eventide Asset Management first reported a position in EVMN in Q4 2025 and held it in 3 quarters. The position peaked at $27.8M in Q1 2026. 99 funds tracked by Wall St. Rank hold EVMN as of Q3 2026.
- Eventide Asset Management reported no remaining Evommune position as of Q3 2026 after selling out during the quarter.
- Eventide Asset Management sold 1,209,129 Evommune shares in Q3 2026, an estimated $16.1M.
- Eventide Asset Management first reported a position in Evommune in Q4 2025 and held it in 3 quarters.
- Eventide Asset Management's Evommune position peaked at $27.8M in Q1 2026.
- 99 funds tracked by Wall St. Rank held Evommune as of Q3 2026.
Based on Eventide Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.